M

Microba Life Sciences Ltd
ASX:MAP

Watchlist Manager
Microba Life Sciences Ltd
ASX:MAP
Watchlist
Price: 0.195 AUD 5.41% Market Closed
Market Cap: 87.3m AUD
Have any thoughts about
Microba Life Sciences Ltd?
Write Note

Intrinsic Value

MAP's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MAP stock under the Base Case scenario is 0.293 AUD. Compared to the current market price of 0.195 AUD, Microba Life Sciences Ltd is Undervalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MAP Intrinsic Value
0.293 AUD
Undervaluation 33%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
Microba Life Sciences Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MAP
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MAP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about MAP?
Bearish
Neutral
Bullish

Fundamental Analysis

0.195 AUD
+5.41%
+5.41%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Microba Life Sciences Ltd
AU
Health Care
Market Cap
87.3m AUD
IPO
Apr 5, 2022
Employees
-
Australia
Market Cap
87.3m AUD
Industry
Health Care
IPO
Apr 5, 2022
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Microba Life Sciences Ltd

Provide an overview of the primary business activities
of Microba Life Sciences Ltd.

What unique competitive advantages
does Microba Life Sciences Ltd hold over its rivals?

What risks and challenges
does Microba Life Sciences Ltd face in the near future?

Has there been any significant insider trading activity
in Microba Life Sciences Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Microba Life Sciences Ltd.

Provide P/S
for Microba Life Sciences Ltd.

Provide P/E
for Microba Life Sciences Ltd.

Provide P/OCF
for Microba Life Sciences Ltd.

Provide P/FCFE
for Microba Life Sciences Ltd.

Provide P/B
for Microba Life Sciences Ltd.

Provide EV/S
for Microba Life Sciences Ltd.

Provide EV/GP
for Microba Life Sciences Ltd.

Provide EV/EBITDA
for Microba Life Sciences Ltd.

Provide EV/EBIT
for Microba Life Sciences Ltd.

Provide EV/OCF
for Microba Life Sciences Ltd.

Provide EV/FCFF
for Microba Life Sciences Ltd.

Provide EV/IC
for Microba Life Sciences Ltd.

Show me price targets
for Microba Life Sciences Ltd made by professional analysts.

What are the Revenue projections
for Microba Life Sciences Ltd?

How accurate were the past Revenue estimates
for Microba Life Sciences Ltd?

What are the Net Income projections
for Microba Life Sciences Ltd?

How accurate were the past Net Income estimates
for Microba Life Sciences Ltd?

What are the EPS projections
for Microba Life Sciences Ltd?

How accurate were the past EPS estimates
for Microba Life Sciences Ltd?

What are the EBIT projections
for Microba Life Sciences Ltd?

How accurate were the past EBIT estimates
for Microba Life Sciences Ltd?

Compare the revenue forecasts
for Microba Life Sciences Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Microba Life Sciences Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Microba Life Sciences Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Microba Life Sciences Ltd compared to its peers.

Compare the P/E ratios
of Microba Life Sciences Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Microba Life Sciences Ltd with its peers.

Analyze the financial leverage
of Microba Life Sciences Ltd compared to its main competitors.

Show all profitability ratios
for Microba Life Sciences Ltd.

Provide ROE
for Microba Life Sciences Ltd.

Provide ROA
for Microba Life Sciences Ltd.

Provide ROIC
for Microba Life Sciences Ltd.

Provide ROCE
for Microba Life Sciences Ltd.

Provide Gross Margin
for Microba Life Sciences Ltd.

Provide Operating Margin
for Microba Life Sciences Ltd.

Provide Net Margin
for Microba Life Sciences Ltd.

Provide FCF Margin
for Microba Life Sciences Ltd.

Show all solvency ratios
for Microba Life Sciences Ltd.

Provide D/E Ratio
for Microba Life Sciences Ltd.

Provide D/A Ratio
for Microba Life Sciences Ltd.

Provide Interest Coverage Ratio
for Microba Life Sciences Ltd.

Provide Altman Z-Score Ratio
for Microba Life Sciences Ltd.

Provide Quick Ratio
for Microba Life Sciences Ltd.

Provide Current Ratio
for Microba Life Sciences Ltd.

Provide Cash Ratio
for Microba Life Sciences Ltd.

What is the historical Revenue growth
over the last 5 years for Microba Life Sciences Ltd?

What is the historical Net Income growth
over the last 5 years for Microba Life Sciences Ltd?

What is the current Free Cash Flow
of Microba Life Sciences Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Microba Life Sciences Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Microba Life Sciences Ltd

Balance Sheet Decomposition
Microba Life Sciences Ltd

Current Assets 32.2m
Cash & Short-Term Investments 21.1m
Receivables 8.1m
Other Current Assets 3.1m
Non-Current Assets 25.8m
PP&E 3.9m
Intangibles 21.9m
Current Liabilities 12.4m
Accounts Payable 4.7m
Accrued Liabilities 1.9m
Other Current Liabilities 5.8m
Non-Current Liabilities 4.5m
Long-Term Debt 373.1k
Other Non-Current Liabilities 4.1m
Efficiency

Earnings Waterfall
Microba Life Sciences Ltd

Revenue
12.1m AUD
Cost of Revenue
-6.2m AUD
Gross Profit
5.9m AUD
Operating Expenses
-27m AUD
Operating Income
-21.1m AUD
Other Expenses
1.1m AUD
Net Income
-19.9m AUD

Free Cash Flow Analysis
Microba Life Sciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MAP Profitability Score
Profitability Due Diligence

Microba Life Sciences Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 1-Year Revenue Growth
Negative Operating Income
28/100
Profitability
Score

Microba Life Sciences Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

MAP Solvency Score
Solvency Due Diligence

Microba Life Sciences Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
Long-Term Solvency
75/100
Solvency
Score

Microba Life Sciences Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MAP Price Targets Summary
Microba Life Sciences Ltd

Wall Street analysts forecast MAP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAP is 0.381 AUD with a low forecast of 0.333 AUD and a high forecast of 0.462 AUD.

Lowest
Price Target
0.333 AUD
71% Upside
Average
Price Target
0.381 AUD
95% Upside
Highest
Price Target
0.462 AUD
137% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MAP?

Click here to dive deeper.

Dividends

Microba Life Sciences Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for MAP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MAP Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one MAP stock?

The intrinsic value of one MAP stock under the Base Case scenario is 0.293 AUD.

Is MAP stock undervalued or overvalued?

Compared to the current market price of 0.195 AUD, Microba Life Sciences Ltd is Undervalued by 33%.

Back to Top